Suppr超能文献

从文献计量学角度看肝硬化疾病中的免疫学因素。

Immunological factors in cirrhosis diseases from a bibliometric point of view.

机构信息

Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

出版信息

World J Gastroenterol. 2023 Jun 28;29(24):3899-3921. doi: 10.3748/wjg.v29.i24.3899.

Abstract

BACKGROUND

Cirrhosis results from persistent liver injury that leads to liver fibrosis. Immunological factors play important regulatory roles in the development and progression of cirrhosis. Bibliometrics is one of the most commonly used methods for systematic evaluation of a field of study. To date, there are no bibliometric studies on the role of immunological factors in cirrhosis.

AIM

To provide a comprehensive overview of the knowledge structure and research hotspots of immunological factors in cirrhosis.

METHODS

We retrieved publications related to immunological factors in cirrhosis between 2003 to 2022 from the Web of Science Core Collection database on December 7, 2022. The search strategy was TS = ((Liver Cirrhosis OR hepatic cirrhosis OR liver fibrosis) AND (Immunologic* Factor* OR Immune Factor* OR Immunomodulator* OR Biological Response Modifier* OR Biomodulator*)). Only original articles and reviews were included. A total of 2873 publications were analyzed using indicators of publication and citation metrics, countries, institutes, authors, journals, references, and keywords by CiteSpace and VOSviewer.

RESULTS

A total of 5104 authors from 1173 institutions across 51 countries published 2873 papers on cirrhosis and immunological factors in 281 journals. In the past 20 years, the increasing number of related annual publications and citations indicates that research on immunological factors in cirrhosis has become the focus of attention and has entered a period of accelerated development. The United States (781/27.18%), China (538/18.73%), and Germany (300/10.44%) were the leading countries in this field. Most of the top 10 authors were from the United States (4) and Germany (3), with Gershwin ME contributing the most related articles (42). was the most productive journal, whereas was the most co-cited journal. Current research hotspots regarding immunological factors in cirrhosis include fibrosis, cirrhosis, inflammation, liver fibrosis, expression, hepatocellular carcinoma, activation, primary biliary cirrhosis, disease, and hepatic stellate cells. Burst keywords (, epidemiology, gut microbiota, and pathways) represent research frontiers that have attracted the interest of researchers in recent years.

CONCLUSION

This bibliometric study comprehensively summarizes the research developments and directions of immunological factors in cirrhosis, providing new ideas for promoting scientific research and clinical applications.

摘要

背景

肝硬化是由持续性肝损伤导致的肝纤维化。免疫因素在肝硬化的发生和发展中发挥着重要的调节作用。文献计量学是系统评估某一研究领域的最常用方法之一。迄今为止,尚无关于免疫因素在肝硬化中的作用的文献计量学研究。

目的

全面概述免疫因素在肝硬化中的知识结构和研究热点。

方法

我们于 2022 年 12 月 7 日从 Web of Science 核心合集数据库中检索了 2003 年至 2022 年期间与肝硬化中免疫因素相关的出版物。检索策略为 TS=((Liver Cirrhosis OR hepatic cirrhosis OR liver fibrosis) AND (Immunologic* Factor* OR Immune Factor* OR Immunomodulator* OR Biological Response Modifier* OR Biomodulator*))。仅纳入原始文章和综述。使用 CiteSpace 和 VOSviewer 分析了出版物和引文指标、国家、机构、作者、期刊、参考文献和关键词,共分析了 2873 篇关于肝硬化和免疫因素的出版物。

结果

来自 51 个国家/地区的 1173 个机构的 5104 位作者在 281 种期刊上发表了 2873 篇关于肝硬化和免疫因素的论文。在过去的 20 年中,相关年度出版物和引文数量的增加表明,对肝硬化中免疫因素的研究已成为关注焦点,并进入了加速发展阶段。该领域的主要国家包括美国(781/27.18%)、中国(538/18.73%)和德国(300/10.44%)。排名前 10 的作者大多来自美国(4 位)和德国(3 位),其中 Gershwin ME 的相关文章最多(42 篇)。是发文量最多的期刊,而被引频次最高的期刊是。肝硬化中免疫因素的当前研究热点包括纤维化、肝硬化、炎症、肝纤维化、表达、肝细胞癌、激活、原发性胆汁性肝硬化、疾病和肝星状细胞。突发关键词(,流行病学,肠道微生物群和途径)代表了近年来引起研究人员兴趣的研究前沿。

结论

本文献计量学研究全面总结了免疫因素在肝硬化中的研究进展和方向,为促进科学研究和临床应用提供了新的思路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验